A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...

The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

The number of common ophthalmic procedures among Medicare beneficiaries overall declined by 17.9% during the COVID-19 pandemic, according to a report published Thursday in JAMA Ophthalmology.

A RETROSPECTIVE case series has identified ophthalmic complications in patients using the antidiabetic drugs semaglutide and ...